Altered Invariant Natural Killer T cell Subsets and its Functions in Patients with Oral Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Altered Invariant Natural Killer T cell Subsets and its Functions in Patients with Oral Squamous Cell Carcinoma

Published:2013-10-27 Issue:5 Volume:78 Page:468-477
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:Scand J Immunol

Author:

Singh A. K.¹,Shukla N. K.²,Das S. N.¹

Affiliation:

1. Department of Biotechnology; All India Institute of Medical Sciences; New Delhi India

2. Department of Surgical Oncology; Dr. BRA-IRCH; All India Institute of Medical Sciences; New Delhi India

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sji.12104/fullpdf

Reference39 articles.

1. World Health Organization The Global Burden of Disease: 2004 Update Geneva World Health Organization http://www.who.int/healthinfo/global_burden_disease/2004_report

2. Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 http://globocan.iarc.fr

3. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis;Das;Cancer Invest,1986

4. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma;Manchanda;Oral Dis,2006

5. The regulatory role of Valpha14 NKT cells in innate and acquired immune response;Taniguchi;Annu Rev Immunol,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes;Frontiers in Immunology;2022-06-16

2. Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment;Frontiers in Medicine;2022-05-09

3. Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial;Clinical and Translational Medicine;2021-07

4. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy;Cancer Research;2021-01-22

5. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma;Oral Oncology;2019-08